annual cash & cash equivalents:
$2.63B-$544.39M(-17.16%)Summary
- As of today (May 31, 2025), ONC annual cash & cash equivalents is $2.63 billion, with the most recent change of -$544.39 million (-17.16%) on December 31, 2024.
- During the last 3 years, ONC annual cash & cash equivalents has fallen by -$1.75 billion (-39.95%).
- ONC annual cash & cash equivalents is now -39.95% below its all-time high of $4.38 billion, reached on December 1, 2021.
Performance
ONC Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$2.52B-$111.00M(-4.22%)Summary
- As of today (May 31, 2025), ONC quarterly cash & cash equivalents is $2.52 billion, with the most recent change of -$111.00 million (-4.22%) on March 1, 2025.
- Over the past year, ONC quarterly cash & cash equivalents has dropped by -$276.96 million (-9.91%).
- ONC quarterly cash & cash equivalents is now -44.46% below its all-time high of $4.53 billion, reached on June 1, 2022.
Performance
ONC quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ONC Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.2% | -9.9% |
| 3 y3 years | -40.0% | -42.1% |
| 5 y5 years | +325.1% | +28.6% |
ONC Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -40.0% | at low | -44.5% | at low |
| 5 y | 5-year | -40.0% | +325.1% | -44.5% | +87.1% |
| alltime | all time | -40.0% | >+9999.0% | -44.5% | >+9999.0% |
ONC Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $2.52B(-4.2%) |
| Dec 2024 | $2.63B(-17.2%) | $2.63B(-2.8%) |
| Sep 2024 | - | $2.70B(+4.2%) |
| Jun 2024 | - | $2.59B(-7.2%) |
| Mar 2024 | - | $2.79B(-11.9%) |
| Dec 2023 | $3.17B(-18.0%) | $3.17B(+3.4%) |
| Sep 2023 | - | $3.07B(-10.1%) |
| Jun 2023 | - | $3.41B(-3.6%) |
| Mar 2023 | - | $3.54B(-8.6%) |
| Dec 2022 | $3.87B(-11.6%) | - |
| Dec 2022 | - | $3.87B(-7.8%) |
| Sep 2022 | - | $4.20B(-7.4%) |
| Jun 2022 | - | $4.53B(+4.2%) |
| Mar 2022 | - | $4.35B(-0.7%) |
| Dec 2021 | $4.38B(+216.6%) | $4.38B(+216.3%) |
| Sep 2021 | - | $1.38B(-22.1%) |
| Jun 2021 | - | $1.78B(-6.6%) |
| Mar 2021 | - | $1.90B(+37.6%) |
| Dec 2020 | $1.38B | $1.38B(-5.6%) |
| Sep 2020 | - | $1.46B(+8.9%) |
| Jun 2020 | - | $1.35B(-31.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $1.96B(+216.7%) |
| Dec 2019 | $618.01M(-13.3%) | $618.01M(-27.8%) |
| Sep 2019 | - | $856.15M(-6.8%) |
| Jun 2019 | - | $918.95M(+20.2%) |
| Mar 2019 | - | $764.49M(+7.2%) |
| Dec 2018 | $712.94M(+197.6%) | $712.94M(+10.8%) |
| Sep 2018 | - | $643.49M(+46.8%) |
| Jun 2018 | - | $438.42M(-10.6%) |
| Mar 2018 | - | $490.63M(+104.8%) |
| Dec 2017 | $239.60M(+173.8%) | $239.60M(+14.9%) |
| Sep 2017 | - | $208.51M(-20.1%) |
| Jun 2017 | - | $261.01M(+167.0%) |
| Mar 2017 | - | $97.75M(+11.7%) |
| Dec 2016 | $87.51M(+389.8%) | $87.51M(+2.3%) |
| Sep 2016 | - | $85.53M(+47.3%) |
| Jun 2016 | - | $58.08M(-72.1%) |
| Mar 2016 | - | $208.51M(+1066.9%) |
| Dec 2015 | $17.87M(+28.6%) | $17.87M(-34.9%) |
| Sep 2015 | - | $27.45M(+9.1%) |
| Jun 2015 | - | $25.16M(+81.0%) |
| Dec 2014 | $13.90M(+254.0%) | $13.90M |
| Dec 2013 | $3.93M | - |
FAQ
- What is BeiGene annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for BeiGene?
- What is BeiGene annual cash & cash equivalents year-on-year change?
- What is BeiGene quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for BeiGene?
- What is BeiGene quarterly cash & cash equivalents year-on-year change?
What is BeiGene annual cash & cash equivalents?
The current annual cash & cash equivalents of ONC is $2.63B
What is the all time high annual cash & cash equivalents for BeiGene?
BeiGene all-time high annual cash & cash equivalents is $4.38B
What is BeiGene annual cash & cash equivalents year-on-year change?
Over the past year, ONC annual cash & cash equivalents has changed by -$544.39M (-17.16%)
What is BeiGene quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of ONC is $2.52B
What is the all time high quarterly cash & cash equivalents for BeiGene?
BeiGene all-time high quarterly cash & cash equivalents is $4.53B
What is BeiGene quarterly cash & cash equivalents year-on-year change?
Over the past year, ONC quarterly cash & cash equivalents has changed by -$276.96M (-9.91%)